Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,042 | 45 | 84.8% |
| Education | $186.82 | 7 | 15.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $209.90 | 8 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $187.17 | 8 | $0 (2019) |
| Boston Scientific Corporation | $114.91 | 1 | $0 (2024) |
| Amgen Inc. | $113.23 | 4 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $82.13 | 4 | $0 (2022) |
| GENZYME CORPORATION | $78.20 | 3 | $0 (2021) |
| Keryx Biopharmaceuticals, Inc. | $48.55 | 2 | $0 (2018) |
| Daiichi Sankyo Inc. | $45.27 | 3 | $0 (2018) |
| Relypsa, Inc. | $44.02 | 3 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $38.53 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $186.37 | 4 | Boston Scientific Corporation ($114.91) |
| 2023 | $51.16 | 3 | AstraZeneca Pharmaceuticals LP ($20.03) |
| 2022 | $21.35 | 1 | Alexion Pharmaceuticals, Inc. ($21.35) |
| 2021 | $76.98 | 4 | Aurinia Pharma U.S., Inc. ($29.04) |
| 2020 | $167.12 | 5 | Otsuka America Pharmaceutical, Inc. ($123.69) |
| 2019 | $166.82 | 8 | Mallinckrodt Enterprises LLC ($52.97) |
| 2018 | $254.79 | 12 | Amgen Inc. ($35.44) |
| 2017 | $304.12 | 15 | Mallinckrodt LLC ($107.61) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.11 | General |
| 06/01/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: NEPHROLOGY | ||||||
| 05/15/2024 | Boston Scientific Corporation | Spyglass (Device) | Food and Beverage | In-kind items and services | $114.91 | General |
| Category: Spyglass DS_ENDO | ||||||
| 05/03/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 12/19/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 12/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/28/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: NEPHROLOGY | ||||||
| 09/16/2022 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.35 | General |
| 09/10/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/29/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Immunology | ||||||
| 06/18/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Hematology | ||||||
| 02/18/2021 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: NEPHROLOGY | ||||||
| 11/14/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: NEPHROLOGY | ||||||
| 11/13/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $95.51 | General |
| Category: NEPHROLOGY | ||||||
| 11/13/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $8.58 | General |
| Category: NEPHROLOGY | ||||||
| 02/28/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Nephrology | ||||||
| 01/03/2020 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Hyperkalemia | ||||||
| 11/22/2019 | GENZYME CORPORATION | CABLIVI (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: RARE BLOOD DISORDERS | ||||||
| 10/11/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Nephrology | ||||||
| 05/10/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 04/12/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: NEPHROLOGY | ||||||
| 04/05/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Immunology | ||||||
| 03/01/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.24 | General |
| Category: NEPHROLOGY | ||||||
| 02/09/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 02/08/2019 | NATUS MEDICAL INCORPORATED | — | Food and Beverage | Cash or cash equivalent | $19.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 751 | 2,347 | $339,491 | $142,186 |
| 2022 | 15 | 718 | 2,069 | $328,505 | $137,703 |
| 2021 | 16 | 832 | 2,740 | $386,288 | $166,370 |
| 2020 | 18 | 984 | 3,055 | $471,901 | $192,481 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 181 | 654 | $68,016 | $40,350 | 59.3% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 21 | 104 | $52,000 | $23,210 | 44.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 45 | 48 | $24,000 | $13,253 | 55.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 115 | 128 | $25,344 | $12,780 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 152 | $30,400 | $11,267 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $20,580 | $8,435 | 41.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 51 | 148 | $44,400 | $8,196 | 18.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 61 | $9,089 | $5,705 | 62.8% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 15 | 71 | $24,850 | $4,736 | 19.1% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 13 | 760 | $17,480 | $4,137 | 23.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 15 | 18 | $6,480 | $4,001 | 61.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 38 | $9,500 | $2,740 | 28.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 16 | $4,640 | $2,181 | 47.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 19 | $1,102 | $711.77 | 64.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 46 | $1,610 | $482.68 | 30.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 164 | 500 | $52,000 | $27,162 | 52.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 14 | 109 | $54,500 | $25,661 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 180 | $36,000 | $15,809 | 43.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 30 | 43 | $21,500 | $12,200 | 56.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 105 | 118 | $23,364 | $11,353 | 48.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 63 | 193 | $57,900 | $10,941 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $18,130 | $8,540 | 47.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 26 | 33 | $11,880 | $7,650 | 64.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 41 | $10,250 | $5,565 | 54.3% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2022 | 11 | 640 | $14,720 | $4,055 | 27.5% |
About Dr. Muhammad Baig, MD
Dr. Muhammad Baig, MD is a Nephrology healthcare provider based in Erie, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1730355256.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Baig, MD has received a total of $1,229 in payments from pharmaceutical and medical device companies, with $186.37 received in 2024. These payments were reported across 52 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,042).
As a Medicare-enrolled provider, Baig has provided services to 3,285 Medicare beneficiaries, totaling 10,211 services with total Medicare billing of $638,740. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Erie, PA
- Active Since 05/05/2008
- Last Updated 04/05/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730355256
Products in Payments
- JYNARQUE (Drug) $192.80
- ACTHAR (Biological) $187.17
- Spyglass (Device) $114.91
- Parsabiv (Biological) $61.02
- Auryxia (Drug) $48.55
- SOLIRIS (Drug) $47.77
- INJECTAFER (Drug) $45.27
- Veltassa (Drug) $44.02
- FABRAZYME (Drug) $34.16
- LUPKYNIS (Drug) $29.04
- Aranesp (Biological) $26.48
- Parsabiv (Drug) $25.73
- Crysvita (Drug) $25.40
- (815) Thiola (Drug) $24.24
- CABLIVI (Drug) $22.38
- CABLIVI (Biological) $21.66
- Velphoro (Drug) $21.24
- FARXIGA (Drug) $20.03
- Rituxan (Biological) $19.63
- ZEPATIER (Drug) $17.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Erie
Dr. Rekha Halligan, M.d., Ph.d, M.D., PH.D
Nephrology — Payments: $172,902
Dr. Asim Singh, M.d, M.D
Nephrology — Payments: $7,509
Dr. Alexander Kosenko, M.d, M.D
Nephrology — Payments: $2,891
Wei-Lung Sam Wu, Md, MD
Nephrology — Payments: $1,888
Dr. Edward Clark, M.d, M.D
Nephrology — Payments: $1,574
Dr. Darren Dreyfus, D.o, D.O
Nephrology — Payments: $1,209